Lindsey Kent
Gerontology · Grand Rapids, MINPI 1740986322
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Boehringer Ingelheim at 25.5% of the total.
Across 86 payments — averaging $35.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$770
- Xeris Pharmaceuticals, Inc.$673
- Medtronic$369
- Novo Nordisk$368
- Tandem Diabetes Care, Inc.$275
- Dexcom, Inc.$194
- plus $367 from 5 others
What the payments were for
- Food & beverage$3,016100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 11 | $770 |
| Xeris Pharmaceuticals, Inc. | 27 | $673 |
| Medtronic | 3 | $369 |
| Novo Nordisk | 29 | $368 |
| Tandem Diabetes Care, Inc. | 4 | $275 |
| Dexcom, Inc. | 4 | $194 |
| Sanofi-aventis U.S. LLC | 3 | $147 |
| BETA Bionics, Inc. | 1 | $138 |
| Sequel Med Tech, LLC | 1 | $29 |
| Lilly USA, LLC | 2 | $29 |
| Insulet Corporation | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$607
- iLet Bionic Pancreas$414
- MINIMED 780G$369
- DEXCOM G7 GSS (161)$128
- Ozempic$125
- GVOKE HYPOPEN$119
- TZIELD$110
How this compares
$3,016 in reported general payments places this provider in the 85th percentile of 279 gerontology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 113 | $141,877 |
| TrulicityDulaglutide | 81 | $112,176 |
| JardianceEmpagliflozin | 31 | $44,314 |
| OzempicSemaglutide | 35 | $37,466 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 102 | $15,856 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $14,693 |
| Humalog Kwikpen U-100Insulin Lispro | 26 | $12,610 |
| Novolog FlexpenInsulin Aspart | 23 | $11,847 |
| Gvoke Hypopen 2-PackGlucagon | 17 | $10,484 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 20 | $3,383 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 12 | $2,450 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 14 | $2,183 |
| Pioglitazone Hcl | 38 | $1,005 |
| Metformin Hcl ErMetformin Hcl | 40 | $941 |
| Metformin Hcl | 19 | $312 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $29 | $254,053194 claims |
| Boehringer IngelheimJardiance | $770 | $44,31431 claims |
| Novo NordiskOzempic | $368 | $37,46635 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 279 gerontology providers in Michigan.
Other gerontology in Grand Rapids
- Angela EmbreeGrand Rapids$10K
- Samantha BurgessGrand Rapids$9K
- Mary GardnerGrand Rapids$8K
- Jennifer LavigneGrand Rapids$6K
- Elizabeth PohlGrand Rapids$5K
- Tanya RowerdinkGrand Rapids$4K
- Lauren JongsmaGrand Rapids$3K
- Kathryn EllensGrand Rapids$3K
- Kaitlin SchoderGrand Rapids$3K
- Allison BrownlowGrand Rapids$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.